Skip to main content
. 2019 Sep 24;42(6):2255–2266. doi: 10.3892/or.2019.7332

Figure 4.

Figure 4.

Prognostic value of key genes associated with ANLN:rs12535394 and their impact on the interactions between ANLN and KDR on breast cancer survival. (A) Prognostic value of MAP10 on breast cancer relapse-free survival, drawn using Kaplan Meier Plotter. (B) Prognostic value of MAP10 on breast cancer overall survival drawn using TCGA data. (C) Expression of MAP10 on breast cancer survival under ANLN low expression, drawn using TCGA data. (D) Expression of MAP10 on breast cancer survival under high expression of ANLN, drawn using TCGA data. (E) Prognostic value of ZNF133 on breast cancer relapse-free survival, drawn using Kaplan Meier Plotter. (F) Prognostic value of ZNF133 on breast cancer overall survival, drawn using TCGA data. (G) Expression of ZNF133 on breast cancer survival under low expression of ANLN, drawn using TCGA data. (H) Expression of ZNF133 on breast cancer survival under high expression of ANLN, drawn using TCGA data. ANLN, anillin actin-binding protein; KDR, kinase insert domain receptor; MAP10, microtubule-associated protein 10; ZNF133, zinc finger protein 133; TCGA, The Cancer Genome Atlas.